Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

3(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

33%

Ph phase_3

22%

Ph not_applicable

11%

Ph phase_4

11%

Ph phase_1

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

3(37.5%)

Phase 3Large-scale testing

2(25.0%)

Phase 4Post-market surveillance

1(12.5%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(4)

Other(1)

Detailed Status

Completed4

Recruiting3

Not yet recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (12.5%)

Phase 23 (37.5%)

Phase 32 (25.0%)

Phase 41 (12.5%)

N/A1 (12.5%)

Trials by Status

not_yet_recruiting111%

unknown111%

recruiting333%

completed444%

Recent Activity

3 active trials

Showing 5 of 9

recruitingphase_2

Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction

NCT06520007

completedphase_4

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

NCT06090565

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT06452394Phase 2

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Recruiting

NCT06329882Phase 1

Doxycycline in Type II Diabetes

Recruiting

NCT05972772Phase 2

Rickettsia Clearance Study

Recruiting

NCT06520007

Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction

Completed

NCT06090565Phase 4

Cefixime Plus Doxycycline Compared to Ceftriaxone Plus Azithromycin for Treatment of Gonorrhoea

Completed

NCT05897034Phase 2

Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Not Yet Recruiting

NCT05545462Not Applicable

Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial

Completed

NCT04584567Phase 3

OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "

Completed

NCT02621359Phase 3

A Two Week Nitazoxanidebased Quadruple Regimen

Unknown

All 9 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 9